Barr Gets License For Generic Actiq As FTC Clears Cephalon-Cima Merger
Cephalon Inc. has granted Barr Laboratories Inc. a license to create a generic version of the pain killer Actiq as part of a deal with antitrust authorities to clear the drug...To view the full article, register now.
Already a subscriber? Click here to view full article